Publications by authors named "Yahveh Zecua-Najera"
[Delayed hypersensitivity reactions to drugs: Group Report of the Drug Allergy Committee of the Mexican College of Clinical Immunology and Allergy (CMICA).].
Rev Alerg Mex
September 2024
Article Synopsis
- Adverse drug reactions (ADRs) can be classified into Type A (pharmacokinetics-related) and Type B (immune response-related), with Type B reactions being less well-defined and often categorized into immediate and delayed types.
- This review aims to explore the immunological mechanisms behind delayed hypersensitivity reactions to medications, highlighting their complexities.
- Findings discuss the classification, clinical signs, diagnosis, treatment plans, and overall prognosis of delayed hypersensitivity, emphasizing the need for prompt, tailored approaches by healthcare professionals.
Background: Any substance used as a treatment for any disease can produce harmful or unpleasant events called adverse drug reactions (ADRs). They are due to inherent biological effects of the drug and are caused by immunological and non-immunological mechanisms.
Objectives: To describe the immunological mechanisms of hypersensitivity reactions (HSR) to drugs, their epidemiology, risk factors, classification, clinical manifestations, diagnosis, treatment, and prognosis.
Background: Asthma is a chronic inflammatory airway disease whose prevalence has increased, especially in developed countries; the results of studies of asthma prevalence vary in different populations and even within the same country; in Mexico we observed fluctuations in prevalence of asthma from 7% to 33%.
Objective: To determine the prevalence of asthma and severity of symptoms as risk indicators in school population in cities in various states of Mexico.
Material And Method: A descriptive study of detection of asthma prevalence and analytical-comparative observational study of determination of symptoms of asthma.
Background: Allergic rhinitis is an inflammatory disorder of the nasal mucosa, characterized by symptoms of itching, rhinorrhea, nasal congestion and sneezing induced by an IgE-mediated response. In Mexico we have reports of prevalence, with fluctuations of 5.5% to 47.
View Article and Find Full Text PDF